Mostrar el registro sencillo del ítem

dc.contributor.authorGutiérrez Fernández, José 
dc.contributor.authorVergara Pavón, María José
dc.contributor.authorGuerrero, M.
dc.contributor.authorFernández, O.
dc.contributor.authorPiédrola Angulo, Gonzalo
dc.contributor.authorMorales, Patricia
dc.contributor.authorMaroto Vela, María del Carmen
dc.date.accessioned2024-03-14T12:17:57Z
dc.date.available2024-03-14T12:17:57Z
dc.date.issued2002-06
dc.identifier.citationGutiérrez, J., Vergara, MJ., Guerrero, M. et al. Multiple Sclerosis and Human Herpesvirus 6. Infection 30, 145–149 (2002). https://doi.org/10.1007/s15010-002-2056-7es_ES
dc.identifier.urihttps://hdl.handle.net/10481/89984
dc.descriptionThis study was supported by the Health Council of Andalusian Regional Goverments, project 141/2001 and the Spanish Federation of Multiple Sclerosis.es_ES
dc.description.abstractBackground: A possible but as yet unproven relationship has been proposed between the onset or persistence of multiple sclerosis (MS) symptoms and herpesviruses, including, most recently, human herpesvirus 6 (HHV-6). A study was conducted to investigate the presence of HHV-6 DNA and the synthesis of antibodies against HHV-6, cytomegalovirus (CMV) and Epstein-Barr virus (EBV) in serum and cerebrospinal fluid (CSF) of patients with MS. Materials and methods: PCR and ELISA were used to detect HHV-6 DNA and specific antibodies against HHV-6, CMV and EBV in 211 samples (139 sera and 72 CSF). There were three groups of samples: group I, paired samples of serum and CSF from 41 MS patients; group II, paired samples of serum and CSF from 31 patients with neurological diseases other than MS (OND); group III, 67 serum samples from 27 different MS patients undergoing serologic follow-up. Results: No HHV-6 DNA was found in any sample. Group I sera showed elevated anti-HHV-6 IgG and IgA levels. In group II, anti-CMV IgG was detected in one CSF sample and anti-HHV-6 IgM in one serum sample. Group III sera showed high concentrations of anti-HHV-6 IgG, IgA and IgM. Conclusion: Given the clinical implications of the presence of antibodies against HHV-6 in MS patients, a viral reactivation cannot be excluded as an environmental factor.es_ES
dc.description.sponsorshipHealth Council of Andalusian Regional Goverments, project 141/2001es_ES
dc.description.sponsorshipSpanish Federation of Multiple Sclerosises_ES
dc.language.isoenges_ES
dc.publisherSpringer Naturees_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectHerpesviruses_ES
dc.subjectMultiple sclerosis es_ES
dc.subjectHHV-6es_ES
dc.subjectCMVes_ES
dc.subjectEBVes_ES
dc.titleMultiple sclerosis and human herpesvirus 6es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.1007/s15010-002-2056-7
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional